Issued Patents All Time
Showing 1–25 of 49 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12043650 | Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene | Anthony J. Conway | 2024-07-23 |
| 11920169 | Compositions for linking DNA-binding domains and cleavage domains | Jeffrey C. Miller, Edward J. Rebar | 2024-03-05 |
| 11661612 | DNA-binding proteins and uses thereof | Philip D. Gregory, Jeffrey C. Miller, Edward J. Rebar, Siyuan Tan, Fyodor Urnov +1 more | 2023-05-30 |
| 11649468 | Targeted integration into the PPP1R12C locus | Russell DeKeiver, Philip D. Gregory, Phillip Tam, Fyodor Urnov | 2023-05-16 |
| 11634463 | Methods and compositions for treating hemophilia | Jeffrey C. Miller, Edward J. Rebar | 2023-04-25 |
| 11512287 | Targeted disruption of T cell and/or HLA receptors | Anthony J. Conway, Sumiti Jain, Gary K. Lee, Edward J. Rebar, Lei Zhang | 2022-11-29 |
| 11492643 | Methods and compositions for treatment of a genetic condition | Gregory J. Cost, Philip D. Gregory, Dmitry Guschin, Michael C. Holmes, Jeffrey C. Miller +4 more | 2022-11-08 |
| 11439666 | Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases | Maria Chiara Bonini, Pietro Genovese, Philip D. Gregory, Michael C. Holmes, Luigi Naldini +2 more | 2022-09-13 |
| 11352631 | Targeted disruption of the T cell receptor | Gary K. Lee, Lei Zhang | 2022-06-07 |
| 11285175 | Targeted disruption of the MHC cell receptor | Gary K. Lee, Lei Zhang | 2022-03-29 |
| 11235026 | Methods and compositions for modulating PD1 | Philip D. Gregory, Michael C. Holmes, Matthew C. Mendel, Xiangdong Meng, Andreas Reik +1 more | 2022-02-01 |
| 11123443 | Htt repressors and uses thereof | Steven Froelich, Jeffrey C. Miller, Edward J. Rebar, Bryan Zeitler, H. Steve Zhang | 2021-09-21 |
| 11041174 | Compositions for linking DNA-binding domains and cleavage domains | Lei Zhang | 2021-06-22 |
| 10968261 | Methods and compositions for genome engineering | Jeffrey C. Miller, Edward J. Rebar, Thomas Wechsler, Lei Zhang | 2021-04-06 |
| 10960085 | Modulation of liver genes | Anthony J. Conway, Gary K. Lee, Lei Zhang | 2021-03-30 |
| 10918668 | Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases | Philip D. Gregory, Michael C. Holmes, Lei Zhang, Maria Chiara Bonini, Pietro Genovese +3 more | 2021-02-16 |
| 10724020 | Compositions for linking DNA-binding domains and cleavage domains | Jeffrey C. Miller, Edward J. Rebar | 2020-07-28 |
| 10538787 | Compositions for linking DNA-binding domains and cleavage domains | Lei Zhang | 2020-01-21 |
| 10500229 | Targeted disruption of the MHC cell receptor | Gary K. Lee, Lei Zhang | 2019-12-10 |
| 10435441 | HTT repressors and uses thereof | Steven Froelich, Jeffrey C. Miller, Edward J. Rebar, Bryan Zeitler, H. Steve Zhang | 2019-10-08 |
| 10407476 | Methods and compositions for treating hemophilia | Jeffrey C. Miller, Edward J. Rebar | 2019-09-10 |
| 10253333 | DNA-binding proteins and uses thereof | Philip D. Gregory, Jeffrey C. Miller, Edward J. Rebar, Siyuan Tan, Fyodor Urnov +1 more | 2019-04-09 |
| 10155011 | Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases | Maria Chiara Bonini, Pietro Genovese, Philip D. Gregory, Michael C. Holmes, Luigi Naldini +2 more | 2018-12-18 |
| 10081661 | Methods and compositions for genome engineering | Jeffrey C. Miller, Edward J. Rebar, Thomas Wechsler, Lei Zhang | 2018-09-25 |
| 10046028 | Methods and compositions for modulating PD1 | Philip D. Gregory, Michael C. Holmes, Matthew C. Mendel, Xiangdong Meng, Andreas Reik +1 more | 2018-08-14 |